Stephen E. Schachterle

Pfizer Inc.

Poster(s):

• (B-216) A Validation Study to Evaluate Code Based Definitions for Sickle Cell Disease, Genotypes, and Acute and Chronic Complications Using US Optum Electronic Health Records
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (B-015) Harnessing Real-World Clinicogenomics for Non-Small Cell Lung Cancer Drug Development: An Initial Report
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET